This subset of tme-lncRNAs was correlated with a previously published tumor-intrinsic transcriptomic signature of RB1 loss, suggesting that proliferative pathways in cancer cells may lead to concomitant changes in the immune microenvironment15. This evidence concerns the gene RB1 and cancer.